Article Search

Journal of Cancer Prevention

All Issue Vol.28 No.3, September 30, 2023
Editor-in-Chief Young-Joon Surh
Journal of Cancer Prevention (JCP; pISSN 2288-3649ㆍeISSN 2288-3657), an official journal of the Korean Society of Cancer Prevention, is an international and peer-reviewed journal. JCP was launched in June 2013 after the title was changed from Journal of Korean Association of Cancer Prevention (from March 1996 to December 2004) and Cancer Prevention Research (from March 2005 to March 2013, ISSN 1738-8015). It is a quarterly journal published on the 30th day of March, June, September, and December. This journal is abstracted/indexed in PubMed Central, Korea Citation Index, e-nest, and Google Scholar. Annual subscription rates with postage (4 issues/year): for foreigners, 250 USD for institutions and 100 USD for individuals; and for Koreans, 100,000 Korean won for institutions and 50,000 Korean won for individuals. For subscription, submission, and all other information, visit our website ( J Cancer Prev is an open access journal. All articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. A free full-text service both in XML and PDF formats is available at our website ( No registration or subscription is required for access to the electronic edition of our journal.

Submit a New Manuscript!

If you want to submit your Manuscript to us, Submit at the Online System now.

Go to Submit

Previous Issues


Aims and Scope

The aim of the journal is to promote an increased awareness of all aspects that ultimately lead to cancer prevention. The journal publishes important original research articles, reviews, editorials, short communications, and letters to the editor with the multi-disciplinary perspectives in the areas of carcinogenesis, chemoprevention, molecular epidemiology, and cancer biology. The journal comprises basic, clinical, and translational research with special attention given to molecular and cellular mechanisms of cancer chemopreventive agents as well as identification of novel risk factors and biomarkers of cancer.

Editorial Office